Un equipo internacional donde participa el Instituto de Biología Molecular y Celular de Plantas (CSIC-UPV) descubre en el microbioma humano una entidad biológica desconocida a la que han llamado ‘...
Read moreThis patent protects a novel technology developed by Oryzon to measure the binding of LSD1 inhibitors such as iadademstat or vafidemstat to their therapeutic target, the epigenetic enzyme LSD1 (also k...
Read moreResearchers from the Clínic-IDIBAPS, along with researchers from the Dana Farber Cancer Institute (DFCI) in Boston, have published a review on dual HER2 inhibition mechanisms, patient selection and r...
Read morehe round was led by imec.xpand with new investors EIC Fund, Fond ICO Next Tech, CDTI-Innvierte and Avançsa. Existing investors Asabys Partners, Aliath Bioventures and Vsquared also participated, brin...
Read moreResearchers of the University of Barcelona and the August Pi y Sunyer Biomedical Research Institute (IDIBAPS) have shown that the IGFBP3 protein plays a relevant role in human lung development.
Read moreA Clínic-IDIBAPS research team is participating in the European Foreum-RA-Flare project, which aims to predict relapses in patients with rheumatoid arthritis in remission through the use of explainab...
Read moreResearch led by IBEC has analysed the antimicrobial activity of human histones against various bacteria, both in solution and in biofilm. The results are very promising and open the door to finding ne...
Read moreThe advancements in biotechnology and the growing concern for global health have highlighted the critical importance of high containment biological facilities (Biosafety Level 3 laboratory and Biosafe...
Read moreEste estudio identifica a PKD2 como un modulador negativo y apunta a que la modulación de la proteína en el hígado podría ser una estrategia terapéutica efectiva para mejorar la resistencia a la ...
Read moreEste estudio describe, por primera vez, la velocidad en la que las personas con trastornos mentales pierden función pulmonar.
Read moreEl trabajo, liderado por el BBRC y publicado en la revista Alzheimer's & Dementia, ha sido clave para conseguir que la Agencia Europea de Medicamentos apruebe esta métrica como un biomarcador válido...
Read moreEl grupo liderado por el catedrático de la UPV/EHU José Luis Vicario ha desarrollado una metodología para desimetrizar ciertas moléculas y obtener un tipo de asimetría molecular que abre la puert...
Read more